UBS lowered the firm’s price target on Danaher (DHR) to $225 from $240 and keeps a Buy rating on the shares. Danaher reported an in-line Q2, but Q3 guidance was slightly below estimates, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DHR:
- Danaher call buyer realizes 36% same-day gains
- Danaher price target raised to $229 from $226 at Baird
- Danaher price target lowered to $205 from $210 at Wells Fargo
- Balanced Outlook for Danaher: Solid Earnings Beat Amidst Cautious Guidance and Mixed Segment Performance
- Danaher: Strong Q2 Performance and Growth Potential Justify Buy Rating